Boomerang Ventures backs KinetiTec in pre-seed round, names Kathy Phlegar CEO
What's the deal? Boomerang VenturesDealroom has a profile for this one. Try Dealroom → has made a strategic pre-seed investment in KinetiTec, an early-stage medtech and SaaS company building SPARK, an in-bed mobility intelligence platform. The investment is a significant portion of KinetiTec's $1M pre-seed round, with $475K committed to date. Alongside the funding, the company has appointed Kathy Phlegar — a medtech veteran with over 20 years of experience scaling healthcare companies — as chief executive officer.
SPARK combines in-bed mobility hardware with cloud-based clinical intelligence to give care teams an objective picture of patient risk, mobility status, and activity progression.
Why now? Patient immobility during hospitalisation is a massive, under-addressed problem. Patients spend more than 90% of their inpatient time in bed, losing over 2% of muscle mass per day. That triggers a cascade of preventable complications — falls, pressure injuries, blood clots, delirium, and prolonged functional decline.
One in three hospitalised patients leaves more disabled than when they were admitted. These complications contribute to an estimated $800M in annual CMS penalties affecting 93% of US hospitals.
The core issue isn't awareness — it's infrastructure. Mobility data is often disconnected from electronic medical records, and staffing constraints limit clinicians' ability to keep patients moving. KinetiTec aims to fill that gap with AI-driven risk stratification, continuous patient engagement beyond scheduled therapy windows, and integrated data visibility.
What could go wrong? KinetiTec is still at the pre-seed stage, with clinical validation ahead of it. Selling into hospitals is notoriously slow and complex, with long procurement cycles and entrenched workflows. The company will also need to prove that its platform delivers measurable outcomes — reduced complications, shorter stays, fewer penalties — to justify adoption.
The signal: Healthcare is increasingly looking to software and hardware platforms that turn qualitative clinical observations into quantifiable, actionable data. KinetiTec fits squarely into this trend, applying the same logic that transformed vitals monitoring to the largely unmeasured domain of patient mobility. If SPARK can prove its clinical and financial value, it could redefine how hospitals think about movement as a standard of care — and open a large market in the process.
Read more: boomerang.vc
